[1] |
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992, 101(6): 1644-1655.
|
[2] |
孙宝房,陈强谱. 腹部外科围手术期过度炎症反应的调控[J]. 世界华人消化杂志, 2017, 25(8): 709-715.
|
[3] |
Stubljar D, Skvarc M. Effective strategies for diagnosis of systemic inflammatory response syndrome (SIRS) due to bacterial infection in surgical patients[J]. Infect Disord Drug Targets, 2015, 15(1): 53-56.
|
[4] |
Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?[J]. Virulence, 2014, 5(1): 20-26.
|
[5] |
Kraft F, Schmidt C, Van Aken H, et al. Inflammatory response and extracorporeal circulation[J]. Best Pract Res Clin Anaesthesiol, 2015, 29(2): 113-123.
|
[6] |
Grootjans J, Lenaerts K, Derikx JP, et al. Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model[J]. Am J Pathol, 2010, 176(5): 2283-2291.
|
[7] |
谈善军,虞文魁,林志亮, 等. 腹腔暴露对大鼠肠黏膜屏障的影响[J]. 肠外与肠内营养, 2015, 22(4): 226-230.
|
[8] |
Grimaldi D, Guivarch E, Neveux N, et al. Markers of intestinal injury are associated with endotoxemia in successfully resuscitated patients[J]. Resuscitation, 2013, 84(1): 60-65.
|
[9] |
Sorkine P, Szold O, Halpern P, et al. Gut decontamination reduces bowel ischemia-induced lung injury in rats[J]. Chest, 1997, 112(2): 491-495.
|
[10] |
Rosero O, Ónody P, Kovács T, et al. Impaired intestinal mucosal barrier upon ischemia-reperfusion: "patching holes in the shield with a simple surgical method"[J]. Biomed Res Int, 2014, 2014: 210901.
|
[11] |
Hartl WH, Jauch KW. Metabolic self-destruction in critically ill patients: origins, mechanisms and therapeutic principles[J]. Nutrition, 2014, 30(3): 261-267.
|
[12] |
Crenn P, Neveux N, Chevret S, et al. Plasma L-citrulline concentrations and its relationship with inflammation at the onset of septic shock: a pilot study[J]. J Crit Care, 2014, 29(2): 315.
|
[13] |
张玮,褚永果,李伟, 等. 肠型脂肪酸结合蛋白和d-乳酸在危重症肠黏膜屏障功能的临床研究[J]. 临床急诊杂志, 2018(1): 6-12.
|
[14] |
Piton G, Capellier G. Biomarkers of gut barrier failure in the ICU[J]. Curr Opin Crit Care, 2016, 22(2): 152-160.
|
[15] |
黎宁君,隋明亮,吴长江, 等. 严重创伤患者早期肠黏膜屏障功能检测的临床意义[J]. 吉林医学, 2017, 60(8): 1437-1440.
|
[16] |
César MMC, da SFP. Intestinal barrier dysfunction in human pathology and aging[J]. Curr Pharm Des, 2016, 22(30): 4645-4650.
|
[17] |
Vaishnavi C. Translocation of gut flora and its role in sepsis[J]. Indian J Med Microbiol, 2013, 31(4): 334-342.
|
[18] |
葛耀植,黄红兰. 肠黏膜屏障功能障碍与细菌易位研究进展[J]. 医学综述, 2018, 24(6): 1072-1076.
|
[19] |
Bishehsari F, Sharma A, Stello K, et al. TNF-alpha gene (TNFA) variants increase risk for multi-organ dysfunction syndrome (MODS) in acute pancreatitis[J]. Pancreatology, 2012,12(2): 113-118.
|
[20] |
Tanno D, Akahori Y, Toyama M, et al. Involvement of Gr-1 dull+ cells in the production of TNF-α and IL-17 and exacerbated systemic inflammatory response caused by lipopolysaccharide[J]. Inflammation, 2014, 37(1): 186-195.
|
[21] |
Kim A, Lang T, Xue M, et al. The Role of Th-17 Cells and γδ T-Cells in modulating the systemic inflammatory response to severe burn injury[J]. Int J Mol Sci, 2017, 18(4): E758.
|
[22] |
Marik PE, Flemmer M. The immune response to surgery and trauma: implications for treatment[J]. J Trauma Acute Care Surg, 2012, 73(4): 801-808.
|
[23] |
de Pablo R, Monserrat J, Prieto A, et al. Role of circulating lymphocytes in patients with sepsis[J]. Biomed Res Int, 2014, 2014: 671087.
|
[24] |
Yao YM, Luan YY, Zhang QH, et al. Pathophysiological aspects of sepsis: an overview[J]. Methods Mol Biol, 2015, 1237: 5-15.
|
[25] |
Rittirsch D, Redl H, Huber-Lang M. Role of complement in multiorgan failure[J]. Clin Dev Immunol, 2012, 2012: 962927.
|
[26] |
Barratt-Due A, Pischke SE, Brekke OL, et al. Bride and groom in systemic inflammation-the bells ring for complement and Toll in cooperation[J]. Immunobiology, 2012, 217(11): 1047-1056.
|
[27] |
Jakkampudi A, Jangala R, Reddy BR, et al. NF-κB in acute pancreatitis: Mechanisms and therapeutic potential[J].Pancreatology, 2016, 16(4): 477-488.
|
[28] |
Yang R, Tenhunen J, Tonnessen TI. HMGB1 and histones play a significant role in inducing systemic inflammation and multiple organ dysfunctions in severe acute pancreatitis[J]. Int J Inflam, 2017, 2017: 1817564.
|
[29] |
Cauwels A, Rogge E, Vandendriessche B, et al. Extracellular ATP drives systemic inflammation, tissue damage and mortality[J]. Cell Death Dis, 2014, 5: e1102.
|
[30] |
Takeuchi O, Akira S. Pattern recognition receptors and inflammation[J]. Cell, 2010, 140(6): 805-820.
|
[31] |
Matsuda N. Alert cell strategy in SIRS-induced vasculitis: sepsis and endothelial cells[J]. J Intensive Care, 2016, 4: 21.
|
[32] |
Sun SC. Non-canonical NF-κB signaling pathway[J]. Cell Res, 2011, 21(1): 71-85.
|
[33] |
Hatakeyama N, Matsuda N. Alert cell strategy: mechanisms of inflammatory response and organ protection[J]. Curr Pharm Des, 2014, 20(36): 5766-5778.
|
[34] |
Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta[J]. Mol Cell, 2002, 10(2): 417-426.
|
[35] |
Schroder K, Tschopp J. The inflammasomes[J]. Cell, 2010, 140(6): 821-832.
|
[36] |
Patel S. Inflammasomes, the cardinal pathology mediators are activated by pathogens, allergens and mutagens: A critical review with focus on NLRP3[J]. Biomed Pharmacother, 2017, 92: 819-825.
|
[37] |
Zhou R, Tardivel A, Thorens B, et al. Thioredoxin-interacting protein links oxidative stress to inflammasome activation[J]. Nat Immunol, 2010, 11(2): 136-140.
|
[38] |
Zmora N, Levy M, Pevsner-Fishcer M, et al. Inflammasomes and intestinal inflammation[J]. Mucosal Immunol, 2017, 10(4): 865-883.
|
[39] |
Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation[J]. Nat Rev Microbiol, 2009, 7(2): 99-109.
|